相关实验视频

Updated: Jun 18, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

CRISPR-Cpf1系统及其在动物基因组编辑中的应用

Yawei Han¹, Zisen Jia², Keli Xu²

¹College of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.

Molecular genetics and genomics : MGG

|July 31, 2024

概括

该CRISPR-Cpf1系统提供准确和高效的基因组编辑,用于创建疾病模型和推进基因疗法. 这项技术在临床前研究中显示出显著的前景,尽管有一些非目标效应.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
生物技术是生物技术.

背景情况:

集群定期间隔的短时间Palindromic重复 (CRISPR) 和CRISPR相关蛋白 (Cas) 系统是一种革命性的RNA引导内核酶基因编辑技术.
由于其精度和高效率,CRISPR-Cas12a,也称为CRISPR-Cpf1,在基因组编辑研究中被广泛使用.

研究的目的:

详细介绍CRISPR-Cpf1技术在构建疾病模型和推进基因疗法的应用.
为CRISPR-Cpf1提供全面的概述,包括其结构,机制以及与CRISPR-Cas9的比较.
分析与CRISPR-Cpf1技术相关的挑战和战略.

主要方法:

介绍了CRISPR-Cas系统的结构和机制.
对CRISPR-Cpf1和CRISPR-Cas9技术进行比较分析.
关注CRISPR-Cpf1在细胞和动物基因组编辑中的应用.
对CRISPR-Cpf1实施的挑战和战略的分析.

主要成果:

克里斯普尔-Cpf1能够有效和准确地编辑细胞和动物基因组.
该技术在临床前研究应用中显示出显著的优势.
确定了非目标效应需要考虑和战略管理.

结论:

CRISPR-Cpf1是基因组编辑的强大工具,特别是在疾病建模和基因治疗研究中.
尽管存在偏离目标的担忧,但其准确性和效率使其在临床前研究中具有价值.
对减轻非目标效应的进一步研究将增强其治疗潜力.

关键词:

动物模型动物模型这就是CRISPR-Cpf1的作用.基因治疗是一种基因疗法.基因组编辑基因组编辑

更多相关视频

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...